WZ4002, a third-generation EGFR inhibitor, can overcome anoikis resistance in EGFR-mutant lung adenocarcinomas more efficiently than Src inhibitors
Yuji Sakuma(Sapporo Medical University), Yohei Miyagi(Kanagawa Cancer Center)
Cited by 47
Related Papers
Identification of Nectin-4 Oncoprotein as a Diagnostic and Therapeutic Target for Lung Cancer
|Cancer Research|2009|291
Dikkopf-1 as a Novel Serologic and Prognostic Biomarker for Lung and Esophageal Carcinomas
|Cancer Research|2007|222
Lipid Droplets: A Key Cellular Organelle Associated with Cancer Cell Survival under Normoxia and Hypoxia
|International Journal of Molecular Sciences|2016|208
Chemotherapy-Induced IL34 Enhances Immunosuppression by Tumor-Associated Macrophages and Mediates Survival of Chemoresistant Lung Cancer Cells
|Cancer Research|2016|178
Wnt Inhibitor Dickkopf-1 as a Target for Passive Cancer Immunotherapy
|Cancer Research|2010|150